Abstract
Tube morphogenesis is essential for internal-organ development, yet the mechanisms regulating tube shape remain unknown. Here we show that different mechanisms regulate the length and diameter of the murine trachea. First, we found that trachea development progresses via elongation and expansion processes. In the first stage, synchronized radial polarization of smooth muscle (SM) progenitor cells with inward Golgi-apparatus displacement regulates tube elongation, controlled by mesenchymal Wnt5a–Ror2 signaling. This radial polarization directs SM progenitor cell migration toward the epithelium, and the resulting subepithelial morphogenesis supports tube elongation to the anteroposterior axis. This radial polarization also regulates esophageal elongation. Subsequently, cartilage development helps expand the tube diameter, which drives epithelial cell reshaping to determine the optimal lumen shape for efficient respiration. These findings suggest a strategy in which straight-organ tubulogenesis is driven by subepithelial cell polarization and ring cartilage development.
Introduction
The delivery systems of multicellular organisms rely on the size and shape of tubular organs 1, 2, and developmental disorders of tubular tissue cause congenital diseases in humans3–5. While organogenesis is progressed by growth factor-based epithelial-mesenchymal interactions, tubulogenesis studies have revealed that de novo luminal formation and the subsequent complex organization of small tubes, such as in mammary and salivary glands and the vascular system, are controlled by mechanical regulations of epithelial cells, involving skeletal structures and differences in cell-cell adhesiveness coordinated by synchronized cellular polarity1, 2, 6–10. However, the contribution of cell polarity in the surrounding mesenchymal cells to tubulogenesis is still unknown11, 12.
The trachea is the exclusive passage for delivering inhalation flow into the lung, which maintains the inhaled air by mucociliary clearance, humidification, and warming prior to entering the alveoli. The tube shape of the trachea determines ventilation efficiency3, 4, 13. The human trachea is about 13-cm long by 2-cm wide, which allows the passage of 30–120 liters of air every minute. The mouse tracheal tube grows to 3-mm long and 500 μm in external diameter by E18.5 (Fig. 1a-d). This large and simple tube is composed of several tissue compartments: endoderm-derived pseudostratified columnar epithelium, and mesoderm-derived mesenchyme including smooth muscle (SM), C-shape cartilage rings (Fig. 1a), vagal nerves as well as blood vessels. Rigid cartilages support the ventral and lateral sides to maintain the tube shape, and SM tissue connects the cartilages at the dorsal side, which also provides elasticity14. Because ventilation efficiency is determined by the tube shape, developmental defects of the tracheal/lung lineage specification or cartilage formation contribute to serious pediatric diseases, such as tracheostenosis and tracheomalacia3, 4, 15.
The embryonic tracheal/lung progenitors originate from the ventral foregut of the early embryo15–17. In the mouse embryo, trachea/lung development is initiated at E9.0 by the separation of these progenitors from the surrounding splanchnic mesoderm. The tracheal anlagen initially arises from the ventral foregut to form a diverticulum, coincident with the invagination of lung buds into splanchnic mesoderm, driven by growth factor-based epithelial-mesenchymal interactions18. The tracheal and lung bud epithelia form a tube structure that begins to elongate in a distal direction. Tracheal SM cell differentiation begins at E11.5 within a restricted area of dorsal tracheal mesenchyme and forms circumferentially bundled structures. Chondrogenesis starts at E14.5 to support the ventral and lateral sides of the tracheal tube. However, the mechanisms underlying tracheal tubulogenesis after the initial separation are poorly understood.
Quantitative analyses of cell shape during tracheal morphogenesis of the fruit fly have elucidated mechanisms for tube length regulation19, 20. In mammals, the branching lung buds have been completely mapped, and the genetic regulations of these complex and stereotyped airway structures have been determined21. Here, to discover the mechanisms underlying mammalian tracheal tubulogenesis, we performed comprehensive quantitative analyses of this process in mouse, from the cellular to whole-organ scale.
RESULTS
The trachea undergoes sequential elongation and expansion processes
We first measured the length and external diameter of developing tracheas (Fig. 1b-d). The tube length was continuously elongated along the anterior-posterior axis, whereas the external diameter was unchanged from E10.5-E14.5. After E14.5, the tube grew in both length and diameter. These observations and previous reports on trachea-esophagus separation18, 22 led us to hypothesize that, after the initial separation (E9.5~E10.5), the developing mouse trachea is shaped via two tubulogenesis steps: phase 1, tube length elongation (E10.5~E14.5), and phase 2, diameter expansion in addition to elongation (E14.5~E18.5) (Fig. 1e).
Although the initial separation is well studied, the subsequent tubulogenesis processes are not well understood. We therefore quantified the epithelial morphogenesis during tracheal tubulogenesis. The luminal-surface area of the developing trachea was measured by a combination of high-resolution micro-CT scanning and 3D-image analysis (Fig. 1f-i and Supplementary Movie 1). Consistent with the gross morphology measurement, the length constantly increased (Fig. 1g). Unlike the external diameter, the internal circumference was expanded throughout embryogenesis (Fig. 1h). The epithelial surface area was undergoing an accelerating expansion (Fig. 1i).
To investigate the mechanisms of tube growth and luminal enlargement, we next evaluated the proportion of proliferating cells in the developing trachea from E12.5 to E18.5 using a BrdU (5-Bromo-2’-Deoxyuridine) incorporation assay. The proportion of proliferating cells peaked at E14.5 in both mesenchyme (59.4%) and epithelium (77.7%) (Fig. 1j, k and Supplementary Fig. 1a). Detailed evaluation with another mitotic marker phospho-HistoneH3 revealed that the cell-proliferation rate peaked precisely at E15.0 (Supplementary Fig. 1b, c). These data revealed that the proliferation rate decreased after E15.0, while the tube diameter and luminal structure were expanding.
To accurately determine the increase in the epithelial cell population during each time period (Nt1/Nt2), we counted the epithelial cells of the entire trachea at several developmental time points (Fig. 1l, upper). This counting was conducted by whole imaging of the tracheal epithelium at single-cell resolution and image analysis using IMARIS. This analyses indicated the almost linear expansion of epithelial cell numbers with modest deceleration (Fig. 1l). The epithelial cell numbers increased 4.23-fold from E12.5 to E14.5 (N14.5/N12.5, Fig. 1l, lower), consistent with the luminal-surface increase (4.41-fold) measured by micro-CT (Fig. 1l, lower), demonstrating that cell proliferation was the major reason for the luminal-surface enlargement until E14.5. After E14.5, unlike the surface enlargement detected by micro-CT, the proliferation rates in both the epithelium and mesenchyme were progressively decreased (Fig. 1k-l). N18.5/N16.5 was only 1.31, whereas the surface area increased 2.87-fold, implying that epithelial cell proliferation was not solely responsible for the luminal-surface enlargement after E14.5. We also observed that the cell-division orientation was random throughout development, suggesting that the directed tube elongation was not elicited by oriented cell division (Supplementary Fig. 2).
These analyses revealed that trachea tubulogenesis is progressed phase 1 “elongation” at and phase 2 “expansion” (Fig. 1e). We further found that there is an accelerating nature of rate of surface area expansion despite of the sudden decrease of proliferating rate after E15.5.
Luminal enlargement
To investigate the mechanism underlying the luminal-surface enlargement that occurs with a low proliferation rate in trachea tubulogenesis phase 2, we examined the cell morphology and alignment of the developing epithelium in detail. At E18.5, the mature trachea has a pseudostratified columnar epithelial structure, which consists of a single layer of columnar luminal cells and flat basal cells (Fig. 1a). We found that from E14.5 to E18.5, the epithelial cells gradually changed shape to generate a typical pseudostratified columnar epithelium (Fig. 2a). To analyze this epithelial cell reshaping quantitatively, we visualized cell membranes and nuclei three-dimensionally in SHHCre; R26RRG mice23, which express membrane-GFP and Histone-H2B-mCherry in the endodermal epithelium, and reconstructed a part of the epithelial structure on a PC. This 3D reconstruction revealed obvious epithelial cell-shape changes during phase 2 (Fig. 2b and Supplementary Movie 2). At E14.5 and E16.5, about 60% of the total population were luminal cells whose apical surface was exposed to the lumen, and 40% were basal-side cells that did not have an apical surface (Fig. 2b, d), and cells of various shapes were packed within a small space. From E16.5 to E18.5, the apical-surface area increased 1.5-fold, and the proportion of luminal cells increased to 80% (Fig. 2b, c), indicating that several basal-side cells had acquired an apical surface. These observations revealed that both “apical enlargement” and “apical emergence” contributed to the luminal-surface enlargement in addition to modest cell proliferation. Integration of these values estimated a 2.90-fold luminal-surface enlargement, due to increased cell numbers (1.31-fold), epithelial cell reshaping including apical enlargement (1.55-fold), and apical emergence (1.43-fold) (Fig. 2e). This integrated value was almost equal to the luminal-surface enlargement quantified by micro-CT (2.87) (Fig. 1i). Thus, these three events were sufficient to explain the luminal area enlargement occurring from E16.5 to E18.5. To assess the impact of excess epithelial cell proliferation in phase 2, we generated Nkx2.1CreERt2; LSL-KrasG12D mice and induced excess proliferation by injecting tamoxifen for three days from E14.5 (Supplementary Fig. 3a-f). Tamoxifen injection increased the phospho-ERK1/2, as a downstream effector of Ras, and the expression of the mitotic marker Ki67, indicating that excessive epithelial cell proliferation occurred in the trachea of the transgenic mice (Supplementary Fig. 3d-f). At E18.5, the Kras-activated epithelium exhibited an altered pseudostratified columnar epithelial structure, accompanied by failed apical enlargement and apical emergence, while the tube shape was intact (Fig. 2f-i, Supplementary Fig. 3a-c, g, h). These data suggested that the regulation of epithelial proliferation during a particular time window is crucial for the epithelial cell reshaping that forms the pseudostratified columnar epithelium but not for tubulogenesis. In contrast to a previous report showing that an epithelial property determines tube morphology1, 2, 7–9, our results suggest that the surrounding mesenchyme restricts epithelial expansion to shape the trachea.
Wnt5a-Ror2 signaling extends the tube
To determine the mechanism of tube elongation in tubulogenesis phase 1, we examined Wnt5a-knockout mice, which have a short trachea phenotype24. We collected the tracheas of Wnt5a−/− mice during development. We found that the tracheal elongation of Wnt5a−/− was defective from E11.5 and reached only 60% of the normal length at E18.5 (Fig. 3a, b). The Wnt5a−/− trachea showed a similar proliferation rate in the epithelium and mesenchyme, and a similar epithelial cell number per area, as the control (Supplementary Fig. 4a-c). The number of cartilage rings decreased from 13 ± 1 to 6 ± 1, while their shape and periodicity were retained (Fig. 3a, Supplementary Fig. 4d). A delay in tube elongation appeared at E11.5 and the tube remained shorter than normal thereafter (Fig. 3b), suggesting that Wnt5a regulates the trachea length in phase 1. We therefore examined the time and pattern of Wnt5a mRNA expression by in situ hybridization. Intense Wnt5a expression was detected in the splanchnic mesenchyme surrounding the trachea epithelium at E10.5 and E11.5 (Fig. 3c), indicating that Wnt5a is secreted from mesenchymal tissue during tube elongation. Next, we conditionally deleted Wnt5a from the splanchnic mesoderm and definitive endoderm by generating Foxg1Cre; Wnt5aflox/flox and SHHCre; Wnt5aflox/flox mice, respectively. The mesodermal mutant, but not the endodermal mutant, showed the short trachea phenotype while the body appearance was indistinguishable from control (Fig. 3d, e and Supplementary Fig. 5a, b). Heterozygotes and homozygotes of the Foxg1Cre allele did not exhibit gross changes in the tracheal morphology (Supplementary Fig. 5c-f). Although Foxg1Cre targets a minor epithelial population25, the epithelial Wnt5a also did not appear to have a role in tube elongation. We further deleted Wnt5a using another mesenchyme-specific Cre-line, Dermo1Cre. The Dermo1Cre, Wnt5aflox/flox mice showed a short trachea phenotype similar to that of Foxg1Cre, Wnt5aflox/flox mice (Supplementary Fig. 5k, l). These data indicated that the mesenchymal Wnt5a functions in tube elongation.
We next sought to identify the receptor for the mesenchymal Wnt5a involved in tracheal elongation. Wnt5a activates non-canonical Wnt signaling via Ror1/2 receptors to regulate cellular functions including cell polarity26. We found that Ror2, but not Ror1, deletion resulted in the short trachea phenotype at E18.5 (Fig. 3e). Ror1/2 double deletion resulted in a more severe phenotype than Ror2−/− at E12.5, and was a phenocopy of Wnt5a−/− (Fig. 3f, g), indicating that the trachea tube elongation in phase 1 is mainly regulated by Wnt5a-Ror2 signaling and that Ror1 might compensate for the loss of Ror2 expression. To identify the Ror2-expressing cells responsible for tube elongation, we performed immunostaining of the developing trachea. A Ror2-expressing subpopulation was identified in the dorsal tracheal mesenchyme, spatially restricted to areas adjacent to tracheal or esophageal epithelium (Fig. 3h). These cells were exclusive to SM tissue, and the Ror2 expression intensity increased as SM tissue developed. Conditional deletion of Ror2 from splanchnic mesoderm using Foxg1Cre; Ror2flox/flox mice, but not from epithelium using SHHCre; Ror2flox/flox, resulted in remarkably shortened trachea (Fig. 3i, j, Supplementary Fig. 5g, h), demonstrating that the Ror2-expressing mesenchymal cells are involved in tube elongation. These results also indicated that the contribution of epithelial Wnt5a-Ror2 signaling is negligible. Similar to Foxg1Cre; Wnt5aflox/flox, these Foxg1Cre; Ror2flox/flox embryos had a normal body size and shape (Supplementary Fig. 5i, j), excluding the possibility that an abnormal body shape of Wnt5a or Ror2 knockout embryos indirectly disrupted their trachea development.
Radial polarization of subepithelial cells arrange SM morphology
To study the role of Wnt5a-Ror2 signaling in SM development, we first examined the SM cell proliferation by Ki67 staining. The SM cell proliferation was not affected in the Wnt5a−/− trachea (Supplementary Fig. 6a, b). Next, we assessed whether the SM tissue morphology was altered in the Wnt5a−/− trachea. We imaged three-dimensional SM tissue at single-cell resolution by reconstructing multiple Z-stack confocal images of normal or Wnt5a−/− trachea (Fig. 4a). The shapes of individual SM cells were visualized by tracing the cell outlines (Fig. 4b and Supplementary Movie 3). In normal trachea at E12.5, the SM tissue appeared at the dorsal side of the tracheal mesenchyme as a convex sheet along the epithelium. The SM cells were extended circumferentially and arranged in parallel to each other to form bundled structures. In Wnt5a−/− tracheas, although the SM differentiation was unaffected, the SM-cell alignments were altered and the SM tissue structure became flat and thick, suggesting that Wnt5a signaling is necessary for the SM cell shaping and parallel arrangement.
We hypothesized that Wnt5a-Ror2 signaling aligns the SM cells and orients them circumferentially by coordinating polarized cell behaviors of the mesenchymal cells, analogous to the way the planer cell polarity of epithelial cells synchronizes epithelial-cell orientation. Due to the radial layer structure of the SM under the epithelium, we speculated that the SM cells were radially polarized toward the epithelium. We thus examined the polarization of the SM cells by determining the position of the Golgi apparatus and centrosome relative to the nucleus in individual Ror2-positive cells. Interestingly, the Golgi-apparatus and centrosome in SM cells were orientated toward the epithelium at E11.5 and E12.5 (Fig. 4c and Supplementary Fig. 7a). The polarity directions were synchronized and largely perpendicular to the epithelial sheet. The most of tracheal subepithelial cells showed this inward Golgi-apparatus displacement, indicating a radial pattern of SM cell polarity (Supplementary Fig. 7b). This radial cell polarization was observed within the first 3 layers of subepithelial cells. Because the polarity was not synchronized at E10.5, before SM cell differentiation, the radial cell polarization may begin at the onset of the fate determination into SM cells. Wnt5a deletion altered the synchronized cell polarity and deformed the layered SM tissue architecture (Fig. 4a, b, d), indicating that Wnt5a-Ror2 signaling is necessary for synchronizing the subepithelial cell polarization toward the epithelium to coordinate the radial cell polarity and build the proper SM architecture.
To understand how radial cell polarization contributes to SM morphogenesis, we conditionally deleted Ror2 within the splanchnic mesoderm. We confirmed that Ror2-negative SM cells exhibited random polarization, while some Ror2-positive tracheal SM cells resulting from incomplete targeting by Foxg1Cre displayed the proper radial cell polarity (Fig. 4e arrowheads). These observations suggested that Wnt5a-Ror2 signaling plays a cell-autonomous role in the radial cell polarization. In addition, a mosaic deletion of Ror2 was achieved by the inefficient gene-targeting of SM cells using the TaglnCre line (Fig. 4f). While most of the Ror2-positive cells became integrated SM tissue, a few Ror2-negative SM cells were excluded from the subepithelial SM (Fig. 4g, arrowheads). These observations suggested that Wnt5a-Ror2 signaling enables SM cells to intercalate into the subepithelium. Therefore, to examine the migration of SM cells toward the epithelium directly, we performed live imaging of migrating SM cells in a 3-dimensional cell culture system (Supplementary Fig. 8). The developing trachea of TaglnCre, R26RmTmG, in which epithelial cells were labeled red and SM cells were labeled green, was isolated at E12.5 and digested with trypsin to single cells. These cells were then cultured on a glass-bottom dish coated with Matrigel to generate epithelial spheres. The migrating SM cells were observed by inverted multi-photon microscopy (Fig. 4h and Supplementary Movie 4). Normal SM cells within a short distance (200 μm) from an epithelial sphere migrated toward the sphere. In contrast, many Wnt5a-null SM cells maintained their distance from the epithelial spheres, and exhibited random migration (Fig. 4i, j). These observations indicated that Wnt5a is required for directional SM cell migration toward the epithelium, which could be involved in tracheal tube elongation.
We reasoned that circumferentially connected subepithelial SM cells restrict the radial expansion and promote tube elongation in longitudinal axis39. To investigate this possibility, we examined the function of the tracheal SM. We examined airway peristalsis to observe SM contractility, which reflects the contractility of tracheal SM, in ex vivo culture27. Developing lungs were harvested from E11.5 embryos and cultured in the air-liquid interface (ALI) fashion. Live imaging showed stochastic peristalsis of the trachea in control mice (Fig. 5a-c and Supplementary Movie 5). The Wnt5a−/− tracheas showed impaired contractility defined by the contractile rate, although the contractile frequency defined by the contraction and relaxation times was not altered. Thus, the SM in the Wnt5a−/− trachea showed an aberrant contraction. Although we do not think the periodicity is necessary for tube elongation, the static restriction by polarized SM tissue may constrain the epithelial tissue expansion and direct tube elongation along the anterior-posterior axis. Supporting this idea, Wnt5a-knockout or Ror2-knockout tracheas showed an expanded tube diameter and thick mesenchymal tissue (Fig. 5d, e, f). We further generated the SM tissue null trachea by deleting Serum Response Factor (Srf) gene, a crucial transcriptional factor of SM cell differentiation, using the Foxg1Cre line (Supplementary Fig. 9a). The SM-null trachea still retained the radial cell polarity (Supplementary Fig. 9b), suggesting that Wnt5a-Ror2 signaling coordinates the pattering and morphology of the SM progenitor cells via the radial cell polarity prior to SM differentiation at subepithelium. For our surprise, this mutant showed normal tube elongation and subepithelial cells showed circumferential supracellular-continuity of cell morphology likewise those of the normal trachea (Supplementary Fig. 9c, d). Furthermore, the axis of this supracellular connection was randomized in Wnt5a−/− trachea (Supplementary Fig. 9d). These data set imply that Wnt5a-Ror2 signaling plays a key role for forming circumferential cell-cell connection of SM progenitor cells at subepithelium by modulating the radial cell polarity.
We also observed radial cell polarization in the esophageal subepithelial cells (Fig. 5i). As seen in the trachea, in the Wnt5a−/− esophagus, both the synchronized subepithelial cell polarity and morphology of SM were altered, resulting in a short-tube phenotype (Fig. 5g and Supplementary Movie 6). These observations suggested that the mechanism in which Wnt5a-Ror2 signaling promotes long, straight tube morphogenesis is conserved. In contrast, in the gut, the mesenchyme exhibited randomized polarization in normal embryos, and Wnt5a−/− embryos showed no SM morphology phenotype (Fig. 5h). It is reported that epithelial cell intercalation mediated by Wnt5a-Ror2 is critical for tube elongation of the stomach, duodenum, and intestine 28, 29. We confirmed that Ror2 was expressed in the epithelium of the stomach and gut but not in the trachea or esophagus (Supplementary Fig. 10). Thus, different mechanisms are likely to be involved in the tube elongation in the trachea and esophagus versus the stomach and gut.
Cartilage growth expands tube diameter
Next, we investigated the mechanism of tube expansion in tubulogenesis phase 2, which includes a resistance against the subepithelial restriction. Cartilage rings appear juxtaposed with SM to completely surround the tracheal tube14. Developmental cartilage disorders cause tracheal stenosis, because tracheal cartilage rings maintain the trachea’s diameter3, 4, 30. We disturbed tracheal cartilage development by generating Foxg1Cre; Sox9flox/flox mice, in which the splanchnic mesoderm lacks cartilage progenitors14. The mutant trachea developed without cartilage and was obviously narrowed by E18.5, whereas SM development and the tube length were not obviously changed (Fig. 6a-c, Supplementary Fig. 11). The lumen of the no-cartilage trachea became stenosed with a folding epithelial structure (Fig. 6d) due to the loss of mesenchymal rigidity. The total surface area of the no-cartilage trachea was measured by a method combining micro-CT and digital reconstruction. The mutant showed a smaller total luminal area that was 49.7% that of wild type. Notably, the mutant trachea developed normally until E14.5 (Fig. 6a-d), the onset of diameter expansion31 (Fig. 1d). These results indicated that the tube expansion in phase 2 is accomplished by proper cartilage development after E14.5.
Finally, we examined the driving force of epithelial cell reshaping observed from E16.5 to E18.5. We reasoned that the epithelial-cell reshaping is supported by the surrounding cartilage rather than by epithelial intracellular machinery. To evaluate the contribution of mesenchymal architecture to epithelial cell reshaping, we examined the epithelial structure of the no-cartilage tracheas. We performed comprehensive epithelial cell quantification, as in Fig. 2b-d, for the nocartilage tracheas. At E18.5, both apical enlargement and apical emergence were inhibited in the mutant trachea (Fig. 6e-g and Supplementary Movie 7), whereas cell proliferation was unaffected (Supplementary Fig. 12). To characterize the epithelial cell reshaping phenotype, we defined a “pseudostratification index,” as the distribution of the distance from the nuclear centroid to the basement membrane32 (Supplementary Fig. 13a). In wild type, the index started high, and decreased as epithelium developed (Supplementary Fig. 13b-c), reflecting epithelial cell reshaping and pseudostratified columnar epithelium development. The mutant trachea, however, showed a higher index than the control at E18.5 (Fig. 6h, Supplementary Fig. 13d). To exclude the possibility that the Sox9-expressing mesenchyme sends signals to the epithelium to regulate apical rearrangement, we genetically ablated the alpha 1(II) collagen (Col2a1) gene, which is crucial for chondrogenesis under Sox9, using CRISPR-Cas9 genome editing (Supplementary Fig. 14a-c). The Col2a1−/− tracheas exhibited the narrowed trachea phenotype and failed to undergo epithelial reshaping, as seen in Foxg1Cre; Sox9flox/flox, while the Sox9-expressing chondrocytes were still present (Supplementary Fig. 14d-j). We also confirmed that Col2a1−/− did not affect epithelial cell proliferation or differentiation (Supplementary Fig. 14k-n). Given that the loss of Sox9 reduces the basal cells and increase the club cell population14, 33, we conclude that the rigidity of the cartilage contributes to the diameter expansion and epithelial rearrangement in phase-2 tubulogenesis, while Sox9-positive chondrocytes regulate the epithelial cell differentiation via secretary factors. These analyses suggest that epithelial cell reshaping requires the structure of the ring cartilage and epithelial quiescence induced at the appropriate time, as revealed by Nkx2.1CreERt2; LSL-KrasG12D (Fig. 2f). Immunohistochemical analyses failed to detect a clear reshaping of cell-cell adherence or of cytoskeletal or polarity-related proteins during phase 2 (Supplementary Fig. 15), indicating that cartilage ring development is most likely the major factor inducing the epithelial cell reshaping. In developing esophagus that does not have cartilage, epithelial cell reshaping was not detected during E14.5 to 18.5 (Fig. 6i). Thus, cartilage development distinguishes not only tube shape but also epithelial structure of the trachea.
To examine whether Wnt5a-Ror2 signaling plays a role in phase-2 tubulogenesis, we assessed the diameter, cell proliferation, apical enlargement, and apical emergence in Wnt5a−/− embryos at E18.5. Consistent with the phenotype at E12.5, the diameter of the Wnt5a−/− trachea was increased (Fig. 3a, 5e, Supplementary Fig. 16a), whereas the Foxg1Cre, Ror2flox/flox trachea had a diameter similar to that of controls at E18.5 (Supplementary Fig. 16b). These data indicated that Ror2 may not be an exclusive receptor for Wnt5a in phase 2. We further examined the diameter in the Ror1/2 double knockout and observe no morphological difference between Foxg1Cre, Ror2flox/flox, and Foxg1Cre, Ror1/2flox/flox at E18.5 (Supplementary Fig. 16b, c), suggesting that Ror1/2 are not involved in phase 2 tubulogenesis. Given that Wnt5a−/− showed a thickened diameter phenotype at E18.5, we next examined whether Wnt5a might regulate the luminal formation in phase 2 tubulogenesis (Supplementary Fig. 16d, e). Although the area of the apical surface of the epithelial cells in the Wnt5a−/− trachea was smaller than that in the control, apical enlargement occurred in the Wnt5a−/− trachea (Supplementary Fig. 16d). In contrast, the apical emergence was inhibited in the Wnt5a−/− trachea (Supplementary Fig. 16e), suggesting that Wnt5a is involved in apical rearrangement. Given that the Wnt5a−/− trachea showed elongation defects from E11.5 to E14.5, it is possible that the limited length of the Wnt5a−/− trachea restricts the epithelial reshaping.
DISCUSSION
In this study, we established that the SM progenitor polarization and cartilage differentiation differentially regulate the length and diameter of the murine trachea in bi-phasic process. In tubulogenesis phase 1, Wnt5a-Ror2 signaling regulates proper SM morphogenesis by orchestrating the radial SM progenitor cell polarization in the subepithelium, which provides the circumferential restraint that directs tube elongation. In phase 2, developing cartilage rings expand the diameter and indirectly induce epithelial cell reshaping.
Although the mechanism by which Wnt5a-Ror2 signaling synchronizes radial SM progenitor polarization awaits further investigation, we expect that an additional epithelial factor is required to direct the polarity toward the epithelium and that the function of Wnt5a-Ror2 is permissive in SM progenitor cells. Wnt5a is reported to be critical for the development of tracheal cartilage25. In the present study, whole-body Wnt5a deletion did not result in cartilage ring malformation, while it decreased the number of cartilage rings. Thus, we think that the cartilage malformation of the Wlsflox/flox; Dermo1Cre embryos in the previous report resulted from a defect in canonical Wnt signaling.
Our finding demonstrates that Wnt5a-Ror2 signaling controls SM progenitor cell migration toward epithelium by synchronizing radial cell polarity. Disruption of the polarity resulted in altered morphogenesis of SM progenitor cells at subepithelium. Given that intercalating movement is a potential mechanism by which developing tissue is elongated 34, intercalation of SM cell at subepithelium might contribute to trachea tube elongation. We also propose the idea that circumferential cell-cell connection of these subepithelial SM progenitors limits radial expansion of developing trachea and promotes tube elongation. In the present study, we failed to provide direct evidence showing that the intercalation and/or mechanical force in smooth muscle elongates the developing trachea. On the other hand, we have also reported that the potassium channel KCNJ13 is a critical regulator of tracheal tube elongation35. KCNJ13 controls the polarity and alignment of tracheal smooth muscle cells by activating AKT signaling, which is essential for the activation of smooth muscle actin. These data also support the idea that circumferential restriction is involved in trachea tube elongation. Contractility-dependent trachea tubulogenesis is also observed in Drosophila36. In Drosophila tracheal tubes, actin filaments concentrate at the apical cortex of epithelial cells and form circumferential supracellular actin rings like those of mouse tracheal SM in the present study. The distribution pattern and contractility of the actin rings can influence tracheal tube morphology. In addition, radial cell intercalation is known to contribute to tissue elongation across species 34, implying that the developmental strategy behind mouse tracheal tubulogenesis might be evolutionarily conserved.
In general, layers of visceral SM cells line the peripheries of organs and tubes in the body. Although the pathological characteristics of visceral SM tissue has been investigated in human diseases, such as the SM remodeling in chronic inflammation, only a few reports have addressed the physiological significance of SM in organogenesis. In the branching morphogenesis of the bronchiole, the local differentiation of SM cells segregates nascent distal buds by creating epithelial clefts37. In gut development, the sequential differentiation of SM layers generates epithelial villi by generating compressive stresses that lead to epithelial buckling and folding in chick11, whereas local proliferation plays a major role in mouse12. Here we revealed an essential role of SM tissue in the directed tube elongation of developing trachea and esophagus along the anterior-posterior axis in mouse.
Epithelial cell reshaping of developing endoderm is also reported in the intestine38, in which densely populated pseudostratified columnar epithelium is rearranged to columnar epithelium during villus formation in the mid- to late-gastrulation stage. This process is regulated by cytoskeletal organization on epithelial cells. In contrast to the epithelial complexity of the intestinal lumen, the trachea develops a smooth epithelium, which supports efficient ventilation by reducing turbulence. In this study, we also failed to detect a change in the expression or distribution of cell-cell adherent complexes, cytoskeleton, or cell polarity-related molecules in the epithelial cells during cell reshaping (Supplementary Fig. 15). However, it is still possible that endogenous epithelial factors are involved in trachea tubulogenesis. These factors should be explored in future studies. Instead, we found that proliferation was reduced, and that the radial growth of cartilage expanded the luminal surface area, indicating that epithelial cell reshaping is achieved by the timed induction of epithelial quiescence and cartilage development. While the ablation of tracheal chondrocytes impacts epithelial differentiation39, our Col2a1−/− mice demonstrated that Sox9-positive chondrocytes are not sufficient to induce epithelial cell reshaping. This observation indicates that the structure and rigidity of the cartilage, rather than paracrine signals from the chondrocytes, is required for epithelial reshaping. Our findings reveal a strategy for straight-organ tubulogenesis driven by SM progenitor polarization and ring cartilage development.
METHODS
Animals
The animals were housed in environmentally controlled rooms, and all the experimental procedures using animals were approved by the Institutional Animal Care and Use Committee of RIKEN Kobe Branch. We handled the mice in accordance with the ethics guidelines of the institute. To minimalize tissue deformation, in all experiments, embryos were fixed in 4% paraformaldehyde/PBS overnight at 4°C, and then tracheas were dissected. SHHCre, Foxg1Cre, TaglnCre, R26RRG, R26RH2B-EGFP, LSL-KrasG12D, Sox9flox, Wnt5a−/−, Wnt5aflox, Ror1−/−, Ror2−/−, Ror1flox, Ror2flox, Srfflox mice have been generated previously23, 40–48. Nkx2.1CreERT2 mouse was provided by Jackson lab. For mosaic labeling of epithelial cells, Nkx2.1CreERT2 mice were crossed with R26RACTB-mTmG/+ mice. Tamoxifen (0.5 mg; Sigma-Aldrich) was intraperitoneally injected into pregnant mice at E10.5. Embryos were collected at E15.5. To induce the epithelial cell proliferation, Nkx2.1CreERT2 mice were crossed with R26RKrasLSLG12D/+ or R26RKrasLSLG12D/mTmG mice. Tamoxifen (5 mg) was intraperitoneally injected into pregnant mice three times at E14.5, 15.5, and 16.5. Embryos were collected from E14.5 to E18.5.
Nkx2.1dTomato mouse and Col2a1−/− mouse were established with CRISPR/Cas9 genome editing technologies in zygotes. For Nkx2.1dTomato mouse, the frozen eggs were obtained by in vitro fertilization between C57BL/6 oocytes and heterozygous Nkx2.1CreERt2 sperm. To insert a dTomato cassette with a FRT sequence in front of CreER at Nkx2.1-CreER allele, the mixture of 50ng μl−1 crRNA, 100ng μl−1 tracrRNA, 10ng μl−1 donor plasmid, 100ng μl−1 Cas9 protein and 100ng μl−1 Cas9 mRNA was injected into the pronuclei. Two hundreds twenty-nine zygotes were injected and 223 were transferred into pseudopregnant ICR female mice. Fifty-four pups were obtained and one out of them carried the designed Nkx2.1dTomato-FRT-CreER-FRT allele. The germline transmission was confirmed by crossing with C57BL/6, and then the CreER cassette was removed by mating the male mice with ACTB:Flpe B6 female mice 49.
For Col2a1 knockout mice, the frozen eggs were obtained by in vitro fertilization between C57BL/6 oocytes and heterozygous Nkx2.1mTomato. Pronuclear stage frozen eggs were used in this study, and electroporation was performed 50. For electroporation, the eggs were transferred into Opti-MEM I containing 25ng μl−1 crRNA1, crRNA2, 100ng μl−1 tracrRNA, 400ng μl−1 bridge oligo, and 100ng μl−1 Cas9 protein (TAKARA). CUY21 and LF501PT1–10 platinum plate electrode (BEX Co. Ltd) were used, and the electroporation conditions were 30V (3 msec ON +97 msec OFF) 7 times. After electroporation, the zygotes were transferred into pseudopregnant ICR female mice, and then the embryos were collected at E18.5 stage. Genotype was determined by genetic PCR with combination of following primers; F1, 5’-GCAAAGCAGTATTCACCTTCCG-3’, R1: 5’-CTCGAACTCGTGGCCGTTCATG-3’, F2: 5’-GGGCTCTATGGCTTCTGAGGC-3’, R2: 5’-CACCTGCGGTGCTAACCAGCG-3’. Genotype was determined by genetic PCR with combination of following primers; Col2a1 F1, 5’- TGCCACTTAGTTTCACCAACTACC-3’ Col2a1 R1, 5’-GATGAGGGCTTCCATACATCCTTA-3’ Col2a1 F2, 5’- TTGCAGGAAAATTAGGGCCAAAG-3’ Col2a1 R2, 5’- GCAAAACATGGACCAGTGAAATGG-3’ (See Supplementary Fig. 13a, b).
Guide RNA sequences were designed by CRISPR design developed in Zhang laboratory (http://crispr.mit.edu). The crRNA and tracrRNA sequences used for genome editing were synthesized as follows (Fasmac). Nkx2.1-CreER crRNA: GGGCCCCCCCTCGAGGTCGA, Col2a1 crRNA1; GAAUCGUGAACCAGCGAUAAguuuuagagcuaugcuguuuug, Col2a1 crRNA2; CGCUCAUACAUACAAUCGCGguuuuagagcuaugcuguuuug. tracrRNA: AAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGG CACCGAGUCGGUGCU.
Cumulative BrdU incorporation assay
To label almost all of proliferating cells, BrdU (0.1 mg ml−1, Sigma-Aldrich, B5002) were cumulatively injected into pregnant mice four times every 2 h before sacrifice. To measure the proliferating ratio, BrdU+ cells were manually counted between the 1st and 12th cartilage region, based on the sections immunostained for BrdU or pHH3. Before E13.5, when the cartilage did not appear yet, the cells were counted in the entire region of the trachea in sagittal sections.
Measurement of epithelial cell number in entire trachea
SHHCre; R26RH2B-EGFP or SHHCre; R26RH2B-mCherry tracheas were cleared by CUBIC reagent51. Fixed tracheas were soaked in CUBIC reagent-1 with gentle rocking at 37°C for 2 days. After washing with PBS, samples were incubated in CUBIC-2 for 3 days. Images were acquired with LSM710 confocal laser scanning microscope with x25/0.8 NA Imm objectives (Carl Zeiss). Images were acquired under the following conditions: 1,024 × 1,024 pixel size in x, y 0.415 μm, 2.400 μm z-section. Image processing was performed using a ZEN2012 (Carl Zeiss), and Imaris8 (Bitplane). A series of images (Z-stack) were reconstructed in Imaris. To distinguish individual nuclei, we newly created a spot layer and manually removed spots derived from non-specific signals. Finally, the total number of epithelial cells was automatically counted.
Histology
For azan staining, tissue was fixed in Bouin’s fixative solution (Sigma-Aldrich, HT10132). After dehydration, samples were embedded in paraffin and cut into 4 μm. Staining were performed according to manufacture’s instruction (MUTO PURE CHEMICALS Co., Ltd.).
Measurement of the developing trachea size
The length in Fig. 1c, 2h, 3b, 3g, 3j, 6b, Supplementary Fig. 3b, 5h, 14e were determined by the straight line connecting pharynx to primary branch on 2D images. The diameter in Fig. 1d, 2i, 5f, 5g, 6c, Supplementary Fig. 3c, 14f, 16a, 16b were determined by the mediolateral straight line in middle region of the trachea on 2D images. Mouse embryos were fixed in 4% PFA overnight and the tracheas were prepared. Tracheas were imaged by Leica M205 FA.
A combination method of micro-CT scanning and 3D reconstruction were performed to obtain more accurate data set reflecting 3D morphology. The length in Fig. 1g was determined by the curve connecting pharynx to primary branch along luminal surface on 3D images. The internal circumference in Fig. 1h was determined by the curve surrounding luminal surface on 3D images. For micro-CT scanning mouse skins were peeled off to infiltrate solution. Embryos were fixed in Bouin’s fixative solution overnight, and washed in 70% EtOH with saturated Li2CO3 (Nacalai Tesque, 20619–42). ScanXmate-E090S (Comscantecno) was used for micro-CT scanning. Before scanning, samples were soaked in contrast agent, 1% phosphotungstic acid/70% ethanol, with gentle rocking at room temperature. The images were three dimensionally reconstructed by Imaris8.1.2. software. The 3D image of trachea region was cropped, and inverted in order to extract luminal structure. And then, surface properties were created to reconstruct 3D structure of the lumen. Based on these reconstructions, longitudinal length, circumferential length and surface area were measured.
In situ hybridization
For frozen sections, tracheas were incubated in 30% sucrose before embedding in OCT compound. In situ hybridization was performed on frozen sections (16 μm). Wnt5a cDNA (Genbank; NM001256224.1 nucleotids 95–402) was amplified by following primers; 5’-ATA GTC GAC ATG GCT TTG GCC ACG TTT TT-3’ and 5’-ATA GAA TTC ATT TGC ATC ACC CTG CCA AA-3’, and subcloned to pBluescriptII SK. DIG labeled cRNA probe was synthesized with mMESSAGE mMACHINE kit (Ambion) and DIG RNA labeling mix (Roche Life Science). Sections were permeabilized in 0.1% Triton X-100/PBS for 30 min and blocked in acetylation buffer. After pre-hybridization, sections were hybridized with DIG-labeled RNA probe (500 ng mL−1) overnight at 65°C. Subsequently, sections were washed, and incubated with anti-DIG-AP antibodies (1:1,000, Roche Life Science, 11 093 274 910), and colored with BM-purple (Roche Life Science, 11442074001).
Immunostaining
For paraffin sections, tracheas were dehydrated and embedded in paraffin. Sections (6 or 8 μm) were stained with primary antibodies listed in Supplementary Table 1. Secondary antibody conjugated with Alexa Fluor 488/594/647 were used. F-actin was visualized by Alexa Fluor 488 Phalloidin (1:1,000, Thermo Fisher Scientific, A12379). DAPI (nacarai tesque) and TOPRO-3 (1:1,000, Thermo Fisher Scientific, T3605) were used as nuclear counterstain. Detailed procedure were listed in Supplementary table 1.
Images were obtained with LSM710 or LSM780 confocal laser scanning microscope with x63/1.4 NA Oil and x25/0.8 NA Imm objectives (Carl Zeiss).
Whole trachea staining
For epithelium staining, after fixation, samples were blocked in 5% normal donkey serum/PBS, and incubated with CDH1 antibody (1/800, Cell Signaling Technology). The following day, samples were washed five times for 1 h, and then, incubated overnight with secondary antibody conjugated with Alexa Fluor 488 (1/500, Thermo Fisher Scientific) and TOPRO-3 (1/500, Thermo Fisher Scientific). After washing, tracheas were cut in the coronal plane, and their ventral epithelium was imaged. For SM staining, samples were blocked in 5% FBS (v/v), 3% BSA (w/v), 0.5% Triton X-100/PBS (v/v), and incubated with Cy3 conjugated SMA antibody (1/400, Sigma-Aldrich) and TOPRO-3 (1/500, Thermo Fisher Scientific). The following day, samples were washed five times for 1 h, and then fixed in 4% PFA/PBS for 1 h again. Samples were soaked into CUBIC reagent-1 with gentle rocking at 37°C overnight. After washing with PBS, samples were incubated with CUBIC reagent-2 at 37°C overnight. For cartilage staining, samples were blocked in 5% FBS (v/v), 3% BSA (w/v), 0.5% Triton X-100/PBS (v/v), and incubated with Sox9 antibody (1/400, Millipore) and TOPRO-3 (1/500, Thermo Fisher Scientific). The following day, samples were incubated with secondary antibody conjugated with Alexa Fluor 488 (1:500) at 4°C overnight, and washed five times for 1 h, and then fixed in 4% PFA/PBS for 1 h again. Samples were soaked into CUBIC reagent-1 with gentle rocking at 37°C overnight. After washing with PBS, samples were incubated with CUBIC reagent-2 at 37°C overnight. Cleared tracheas were imaged by confocal LSM710 confocal laser scanning microscope with x25/0.8 NA Imm objectives (Carl Zeiss).
3D culture of epithelial cells and SM cells from the trachea
The epithelial and SM cells were prepared from TaglnCre; R26RACTB-mTmG/+ or TaglnCre; R26RACTB-mTmG/+; Wnt5a−/− mouse tracheas at E12.5, as follows. The tracheas were digested in 0.25% trypsin for 10 min. The cells were passed through a 40-μm cell strainer, and then trapped in 50% Matrigel/mTEC-plus on a 35-mm glass-bottom dish. The cells embedded in Matrigel were covered with mTEC-plus medium supplemented with 10 μM Y-27632. After day 2, the cells were maintained in mTEC-plus without Y-27632.
For time-lapse imaging, the cells on day 3 were imaged every 1 h for 24 h by an Olympus LCV-MPE (multiphoton/incubator) or an Olympus LCV-CSUW1. The images were acquired with the following conditions: 1,024 × 1,024 pixel size in x, y 0.415 μm, 2.0 μm z-section. Image processing was performed using Image J (NIH), and Imaris 8.1.2 (Bitplane).
For quantification, cells were manually traced by Image J. The approaching distance was defined as the remainder after subtracting the final distance between the SM cell and the epithelial-cell sphere from the initial distance (Supplementary Fig. 8). Directionality was indicated by the angle between the 2 vectors and (Supplementary Fig. 8), where A was the initial position of the SM cell, B was the initial position of the sphere, and A’ was the final position of the SM cell.
Peristalsis analysis
After dissection of the internal organs including the trachea from Wnt5a−/− and control littermates at E12.5, the organs were transferred onto the membrane (Nucleopore Track-Etch Membrane (8 μm pore size), Whatman) in DMEM/Ham’s F12 medium with 5% FBS. For live imaging, the trachea in the organs was cultured for 24 h, and then imaged for 10 min every 1 second by DeltaVision2 (Olympus). For measurement of the max contractility, the diameter of the trachea was measured every second during contraction. We defined maximum contractility as the rate of minimum diameter to maximum diameter.
Quantification of epithelial rearrangement
SHHCre; R26RRG and SHHCre; R26RRG; Wnt5a−/− tracheas were fixed in 4% PFA/PBS and coronally opened in PBS(-). For the analyses of Nkx2.1mTomato; Col2a1−/− mice, mice were fixed in 4% PFA at 4°C overnight and tracheas were collected. After wash with PBS(-), tracheas were made transparent by sequential incubation in CUBIC regent1/2. Epithelium of the ventral side was imaged by a confocal LSM710 confocal laser scanning microscope with x25/0.8 NA Imm objectives (Carl Zeiss). Images were acquired under the following conditions: 1,024 × 1,024 pixel size in x, y 0.332 μm, 2.000 μm z-section. Images were processed using ZEN (Carl Zeiss), Imaris (Bitplane), and Image J (NIH). For the analyses of Foxg1Cre; Sox9flox/flox mice, tracheas were stained for CDH1 and TOPRO-3 as described above. For apical area measurement, we selected a relatively flat region to avoid the influence by tissue folds and manually followed the apical shape contour. For the luminal cell ratio, we manually counted the numbers of luminal cells, which were attached to the lumen, and the non-apical basal cells. The psuedostratification index was determined as described previously with some modification32. In optical images along the AP-axis, the contours of the nucleus were followed to calculate the x, y-coordinates of the centroid. The distance between the nucleic centroid and the basal membrane was measured as the pseudostratification index.
Quantification of SM cell polarity
All quantification was based on the sagittal sections stained for GM130, Ror2, and TOPRO-3 as described above. The contours of the plasma membrane in Ror2-expressing SM cells were manually traced to calculate the x, y-coordinates of the centroid in sagittal sections. The orientation of SM cells was judged by the relative x, y-coordinates of the nucleic centroid and Golgi apparatus. The distribution of the orientations was expressed as rose charts.
Statistics
Statistical analyses were performed with Excel2013 (Microsoft). For multiple comparisons, statistic significance was determined by Tukey’s method. For paired comparisons, statistic significance was determined by Student’s or Welch’s two-tailed t-test for equal or unequal variance populations, respectively.
Data availability
The authors declare that all data supporting the findings of this study are available within the article and its supplementary information files or from the corresponding author upon reasonable request. The datasets generated during the current studies are available in System Science of Biological Dynamics (SSBD) database (http://ssbd.qbic.riken.jp/).
Author Contributions
K.K. and M.M. designed the project and performed experiments with the aid of A.Y.. M.T. performed the micro-CT experiments. M.N. and Y.M. provided Ror2 antibody and Ror1, 2 conditional KO mice, and supported data interpretation. Col2a1 KO mice and Nkx2.1-mTomato were generated by T. A. and M. S.. K.K. and M.M. wrote the manuscript with the contribution of all the authors.
Competing interests
The authors declare no competing any interests.
Acknowledgment
We thank Terry Yamaguchi and Reiko Ajima for the Wnt5a conditional flox mice, Michael Eldon Greenberg for Ror1 conditional flox mice, Hiroki Ueda for the Sox9 conditional flox mice, Mark Krasnow and Maya Kumar for the Tbx4-Cre mice, Steven L. Brody for the anti-Foxj1 antibody, and the CDB 4D Imaging Unit and Animal Resource Development Unit as well as Cellular Dynamics Analysis for support. We also thank Masako Yamaguchi for supporting IMARIS works; Masatoshi Takeichi, Shigeo Hayashi, Didier Stainier and Brigid Hogan for primary reading; and Chisa Matsuoka and Yuka Noda for general technical support. These studies were supported by funding from Grants-in-Aid for Young Scientists (B) (No. 17K15133) of the Ministry of Education, Culture, Sports, Science and Technology, Japan (K.K.), and The Takeda Science Foundation for the Life Science (M.M.), and RIKEN Single Cell Project (M.M.) Scientific Research on Innovative Areas of the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 23112004) (M.M.).